Patent · US Active

Mucin hypersecretion inhibitors and methods of use

US8492518B2 · kind B2 · utility

4Cited by
16References
18Claims
0Family size

Assignee

Inventor

Key dates

Filing dateApr 27, 2009
Grant dateJul 23, 2013
Priority date
Expiry dateApr 27, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Peptides are provided that comprise less than 24 amino acids. The peptides have an amino acid sequence selected from the group consisting of: (a) an amino acid sequence having from 4 to 6 contiguous amino acids of a reference sequence PEPTIDE 1; (b) an amino acid sequence substantially identical to the sequence defined in (a); and (c) a variant of the amino acid sequence defined in (a). Also provided is a non-myristoylated MANS peptide. Various methods of using the peptides are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.